Progyny, Inc. Operating Cash Flow

Operating Cash Flow of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow growth rates and interactive chart. Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations, otherwise it may require external financing for expansion or even survival. A negative number means the company is funded through external capital (debt or equity issuance) or cash available on the balance sheet. A positive number means that a company generates enough cash to pay for its operations.


Highlights and Quick Summary

  • Operating Cash Flow for the quarter ending June 29, 2021 was $-7.47 Million (a -1504.7% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow decreased by -148.75%
  • Annual Operating Cash Flow for 2020 was $36.2 Million (a -2460.04% decrease from previous year)
  • Annual Operating Cash Flow for 2019 was $-1.53 Million (a -167.52% decrease from previous year)
  • Annual Operating Cash Flow for 2018 was $2.27 Million (a -123.98% decrease from previous year)
  • Twelve month Operating Cash Flow ending June 29, 2021 was $14.9 Million (a -39.32% decrease compared to previous quarter)
  • Twelve month trailing Operating Cash Flow decreased by -38.27% year-over-year
Trailing Operating Cash Flow for the last four month:
29 Jun '21 30 Mar '21 30 Dec '20 29 Sep '20
$14.9 Million $24.6 Million $36.2 Million $24.2 Million
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow of Progyny, Inc.

Most recent Operating Cash Flowof PGNY including historical data for past 10 years.

Interactive Chart of Operating Cash Flow of Progyny, Inc.

Progyny, Inc. Operating Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-7.47 $0.53
2020 $6.54 $15.33 $2.2 $12.14 $36.2
2019 $-5.49 $5.88 $4.25 $-6.17 $-1.53
2018 $4.1 $-0.55 $-1.28 $2.27
2017 $-9.47 $-9.47

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.